Synonyms:
Status: Phase 2
Entry Type: Oligonucleotide
Molecule Category: Salt
UNII: CI002S7WH8
Parent Compound: CENERSEN

Pharmacology

Action Mechanism of Action Reference
ANTISENSE INHIBITOR p53 mRNA antisense inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials

Related Entries

Parent

Cross References

Resources Reference
ChEMBL CHEMBL2219776
FDA SRS CI002S7WH8
PubChem 56841947